venetoclax prodrug with reduced food effect

enhanced bioavailability in healthy volunteers

from venetoclax heterocycle N-alkylation

Mol. Cancer. Ther. Mar. 30, 2021

AbbVie, North Chicago, IL

Structure of the AbbVie BCL-2 inhibitor prodrug (ABBV-167)

The AbbVie BCL-2 inhibitor prodrug (ABBV-167) is a phosphate prodrug of venetoclax used for treatment of chronic lymphocytic leukemia (CLL). This molecule has an interesting prodrug mechanism, masking an…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: